Michael E. Perlman,Ravi M. Shanker,Walter C. Babcock,Dwayne Thomas Friesen,Mark D. Rabenstein,Daniel Tod Smithey
申请号：
US15268441
公开号：
US20170000733A1
申请日:
2016.09.16
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A pharmaceutical composition comprises a solid amorphous dispersion comprising a low-solubility drug and a concentration-enhancing polymer and a lipophilic microphase-forming material. Alternatively, a solid amorphous dispersion comprising a low-solubility drug and a concentration-enhancing polymer is co-administered with a lipophilic microphase-forming material to an in vivo use environment.
